“…The MMPI-2-FBS is a generally accepted measure of symptom overreporting in personal injury settings (Sharland & Gfeller, 2007), is sensitive to exaggerated disability in persons seeking benefits for ambiguous neurological trauma (Greiffenstein, Fox, & Lees-Haley, 2007), and is supported by more than 45 original research studies (Greiffenstein et al, 2007). This evidence includes MMPI-2-FBS association with illogical symptom histories (Greiffenstein, Baker, Axelrod, Peck, & Gervais, 2004;Greiffenstein, Baker, Gola, Donders, & Miller, 2002), failed cognitive effort tests (Gervais, Ben-Porath, Wygant, & Green, 2007;Larrabee, 2003a;Wygant, Sellbom, et al, 2007), known medical simulation (Wygant et al, 2009), unusual chemical exposure claims (Binder, Storzbach, & Salinsky, 2006;Staudenmayer & Phillips, 2007), and settings historically associated with secondary gain, such as chronic pain clinics (Bianchini, Etherton, Greve, Heinly, & Meyers, 2008;Butcher, Arbisi, Atlis, & McNulty, 2003). A recent meta-analysis documented the incremental validity of the FBS when compared with all other MMPI-2 validity scales (Nelson, Sweet, & Demakis, 2006).…”